EMPLOYMENT AGREEMENTEmployment Agreement • March 17th, 2008 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 17th, 2008 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 14th day of March, 2008, to be effective as of May 1, 2008 (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Dennis P. Reilly (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 17th, 2008 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 17th, 2008 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 14th day of March, 2008, to be effective as of April 1, 2008, (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Alfred Altomari (the “Executive”).
EMPLOYMENT AGREEMENTEmployment Agreement • May 16th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMay 16th, 2007 Company Industry JurisdictionTHIS EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 16th day of May, 2007 (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Braham Shroot, Ph.D. (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 12th, 2007 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6th day of December, 2006 (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Albert C. Bristow (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 12th, 2007 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6th day of December, 2006 (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Geert Cauwenbergh, Ph.D. (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 12th, 2007 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6th day of December, 2006 (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Al Altomari (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 12th, 2007 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6th day of December, 2006 (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Anne VanLent (the “Executive”).
AMENDED AND RESTATED EMPLOYMENT AGREEMENTEmployment Agreement • March 12th, 2007 • Barrier Therapeutics Inc • Pharmaceutical preparations • New Jersey
Contract Type FiledMarch 12th, 2007 Company Industry JurisdictionTHIS AMENDED AND RESTATED EMPLOYMENT AGREEMENT (the “Agreement”) is entered into this 6th day of December, 2006 (the “Effective Date”) by and between Barrier Therapeutics, Inc., a Delaware corporation having its principal offices in Princeton, New Jersey (the “Company”), and Charles T. Nomides (the “Executive”).